Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Myriad Genetics Inc (MYGN)

Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
3 Cash-Burning Stocks We Keep Off Our Radar

3 Cash-Burning Stocks We Keep Off Our Radar

FLWS : 3.56 (-3.52%)
TLYS : 1.3900 (+0.72%)
MYGN : 4.49 (-0.88%)
1 Small-Cap Stock on Our Watchlist and 2 That Underwhelm

1 Small-Cap Stock on Our Watchlist and 2 That Underwhelm

MYGN : 4.49 (-0.88%)
DBI : 7.19 (+8.61%)
BGC : 9.21 (-3.05%)
Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data

SALT LAKE CITY, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced a commercialization roadmap...

MYGN : 4.49 (-0.88%)
2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm

2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm

MYGN : 4.49 (-0.88%)
MRK : 121.41 (+1.82%)
CAH : 220.79 (+2.66%)
Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance

SALT LAKE CITY, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced select unaudited preliminary...

MYGN : 4.49 (-0.88%)
Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference

SALT LAKE CITY, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Sam Raha, president and...

MYGN : 4.49 (-0.88%)
3 Stocks Under $10 We Think Twice About

3 Stocks Under $10 We Think Twice About

SSP : 3.48 (-1.69%)
TH : 7.15 (+0.99%)
MYGN : 4.49 (-0.88%)
3 Unprofitable Stocks That Fall Short

3 Unprofitable Stocks That Fall Short

W : 82.39 (-0.16%)
MYGN : 4.49 (-0.88%)
JACK : 20.73 (+1.12%)
Myriad Genetics (MYGN) Stock Trades Up, Here Is Why

Myriad Genetics (MYGN) Stock Trades Up, Here Is Why

MYGN : 4.49 (-0.88%)
Why Myriad Genetics (MYGN) Stock Is Up Today

Why Myriad Genetics (MYGN) Stock Is Up Today

MYGN : 4.49 (-0.88%)

Barchart Exclusives

3 Highest-yielding Dividend Aristocrats That'll Pay You For Generations
When headlines get messy, reliable, passive income is the ultimate comfort. Discover three high-yield Dividend Aristocrats screened for consistent payouts and cash flow growth. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar